Recommendations Updated for Diagnosis, Management of COPD

Share this content:
Recommendations Updated for Diagnosis, Management of COPD
Recommendations Updated for Diagnosis, Management of COPD

THURSDAY, Feb. 2, 2017 (HealthDay News) -- Recommendations have been updated for diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD), according to the Global Initiative for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease (GOLD) report published online Jan. 27 in the American Journal of Respiratory and Critical Care Medicine.

Claus F. Vogelmeier, M.D., from the University of Marburg in Germany, and colleagues address diagnosis, management, and prevention of COPD, focusing on new recommendations for assessing COPD, strategies for escalation and de-escalation of therapies, and discussion of nonpharmacologic treatments.

The authors note that the most significant changes in the report include refinement of COPD assessment in order to separate spirometric assessment from evaluation of symptoms based on the "ABCD" grouping. They propose deriving the ABCD groups exclusively from patient symptoms and their history of exacerbations. Escalation strategies are proposed for pharmacologic treatments for each of groups A to D; the concept of de-escalation of treatment should be considered for patients in whom symptoms resolve. The authors also discuss non-pharmacologic therapies, including pulmonary rehabilitation, exercise training, oxygen therapy, vaccinations, interventional bronchoscopy, and surgery, as well as end-of-life and palliative care. The importance of treating comorbidities, which often occur, and of managing COPD in the presence of comorbid conditions is also highlighted.

"The latest report revises the GOLD document in important ways based on the latest scientific and clinical studies," a coauthor said in a statement.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »